logo
Select company
Select metric
$ 10.89MNet Cash Flow - Financing
VS
Market
32
Sector
42
Industry
51
History
38
$ 1.11Close
$ 0.77 - $ 1.54 52-Week Range
Ticker Information

Ticker

RNXT

Company Name

RENOVORX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RENOVORX INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNXT - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 10.89M
3/31/2025$ 20.51M
12/31/2024$ 15.12M
9/30/2024$ 15.09M
6/30/2024$ 15.07M
3/31/2024$ 10.42M
12/31/2023$ 5.01M
9/30/2023$ 5.01M
6/30/2023$ 5.01M
3/31/2023$ 22K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RENOVORX INC's latest trailing twelve months (TTM) CF - Financing stands at $ 3.2M.
  • Over the past 5 years, RENOVORX INC's average CF - Financing has been $ 8.91M.
  • The median CF - Financing for RENOVORX INC during this period was $ 7.72M
  • RENOVORX INC reached its highest CF - Financing over the past 5 years at $ 20.51M.
  • The lowest CF - Financing recorded by RENOVORX INC in the same timeframe $ 22K

RENOVORX INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
ADVM : ADVERUM BIOTECHNOLOGIES INC $ 359KRLYB : RALLYBIO CORP $ 17KICU : SEASTAR MEDICAL HOLDING CORP $ 20.48MLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MCLNN : CLENE INC $ 3.27MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 8.43MBRTX : BIORESTORATIVE THERAPIES INC $ 1.85MVTGN : VISTAGEN THERAPEUTICS INC $ 4.61MLYRA : LYRA THERAPEUTICS INC $ 4.62MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 7.09M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

RNXT - Net Cash Flow - Financing, Last 5 years

$ 22K

Minimum

Mar 31, 2023

$ 20.51M

Maximum

Mar 31, 2025

$ 8.91M

Average

$ 7.72M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M